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Background and purpose — For more than half a century, 
stemmed hemiarthroplasty (SHA) has been used in the treatment 
of comminuted and displaced fractures of the proximal humerus. 
Reverse shoulder arthroplasty (RSA) has been increasingly popu-
lar in cases where it is diffi cult to obtain satisfactory fi xation of 
the tuberosities. We report revision rates and reasons for revision 
after shoulder arthroplasty for acute fractures of the proximal 
humerus.
Patients and methods — This study was based on a common 
dataset from the Nordic Arthroplasty Register Association 
(NARA), which includes data reported to the national shoulder 
arthroplasty registries in Denmark, Sweden, and Norway. We 
included 6,756 shoulder arthroplasties performed for acute frac-
tures between 2004 and 2013.
Results — There were 6,112 SHAs (90%) and 565 RSAs (8.4%). 
The cumulative arthroplasty survival rate after 5 years was 0.96 
for both SHA and RSA. The relative risk of revision of RSA was 
1.4 (95% CI: 0.9–2.2) with SHA as reference. For both types of 
arthroplasty, the most common reason for revision was infection 
(SHA 0.8%, RSA 2.1%). The relative risk of revision due to infec-
tion was 3.1 (95% CI: 1.6–5.9) for RSA with SHA as reference. 
The relative risk of revision for patients who were less than 75 
years of age was 2.8 (95% CI: 2.0–3.8) compared to older patients. 
Interpretation — Revision after shoulder arthroplasty for acute 
fractures was rare. Survival rates were similar between SHA and 
RSA, but RSA had a statistically signifi cant and clinically relevant 
higher risk of revision because of infection. 
■
For more than half a century, stemmed hemiarthroplasty 
(SHA) has been a treatment option for severely commi-
nuted and displaced fractures of the proximal humerus. The 
functional outcome has been regarded as superior to that of 
non-surgical treatment, but recently, randomized trials have 
reported comparable outcomes (Olerud et al. 2011, Boons et 
al. 2012). One of the main reasons for a poor result is non-
union of the tuberosities with subsequent rotator cuff insuf-
fi ciency and joint instability (Hasan et al. 2002).
Reverse shoulder arthroplasty (RSA) has been increasingly 
popular in cases where it is diffi cult to obtain satisfactory fi xa-
tion of the tuberosities (Brorson et al. 2013, Mata-Fink et al. 
2013, Anakwenze et al. 2014). Only 1 small randomized con-
trolled trial reported that the outcome of RSA used for acute 
fractures of the proximal humerus was superior to that of SHA 
(Sebastia-Forcada et al. 2014). There have been few reports of 
arthroplasty survival rates and reasons for revision for SHA—
and particularly for RSA. 
National shoulder arthroplasty registries have been estab-
lished to monitor outcome after shoulder arthroplasty and for 
early detection of inferior arthroplasties (Rasmussen et al. 
2012). The high number of arthroplasties makes the national 
registries suitable for reporting of revision rates and reasons 
for revision. Here we report revision rates and reasons for 
revision of shoulder arthroplasty types used for acute fractures 
of the proximal humerus. 
Patients and methods
This study was based on a common dataset from the Nordic 
Arthroplasty Register Association (NARA), which is a collab-
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oration between the national shoulder arthroplasty registries in 
Denmark, Sweden, and Norway (Rasmussen et al. 2016). The 
dataset contains 19,857 shoulder arthroplasties and covers the 
period 2004–2013. The degree of completeness of reporting 
during the entire study period was 92% in Denmark, 80% in 
Sweden, and 95% in Norway. The dataset includes variables 
on demography (sex, age, and nationality), primary procedure 
(primary diagnosis, date of surgery, arthroplasty type, and 
brand), and revision procedure (date of revision, reason for 
revision, number of revisions, and new arthroplasty type). 
Defi nitions were established through consensus in the 
group of authors (Rasmussen et al. 2016). An acute fracture 
was defi ned as a proximal humeral fracture that was not cat-
egorized as fracture sequelae, regardless of time from injury 
to operation. Fracture sequelae included fractures reported as 
non-union, malunion, previous osteosynthesis, osteoarthritis, 
and humeral head necrosis if reported together with fracture.   
A revision was defi ned as removal or exchange of any com-
ponent or the addition of a glenoid component. We used a 
hierarchy of reasons for revision in cases where more than 
1 reason was reported. Thus, only 1 reason for revision was 
registered (Table 1). Survival rates were calculated using revi-
sions reported to the national registries until December 2013, 
and by checking for deaths in the national population registry 
of each country.  
Statistics
Student’s t-test (for continuous variables) and chi-square test 
(for categorical variables) were used to compare differences 
in demography between SHA and RSA. The Kaplan-Meier 
method including 95% confi dence intervals (CIs) were used 
to analyze the cumulative survival rate, and the log-rank test 
was used for comparison. A Cox regression model was used 
to analyze the relative risk of revision of RSA, with SHA as 
reference. Age, gender, and year of surgery were included in 
the model. 
Although it violated the assumption of independence, 
patients with bilateral replacements were included in the sur-
vival analyses as if they were independent. The level of sta-
tistical signifi cance was set at p < 0.05, and all p-values were 
2-tailed.
Ethics
Ethics committee approval was not required. No competing 
interests declared.
Results
6,756 prostheses were used for acute fractures of the proximal 
humerus between 2004 and 2013. The incidence increased at 
the beginning of the period, but stabilized within the last 5 
years (Figure 1). The number and proportion of RSAs steadily 
increased in the study period. For the group of patients treated 
with an RSA, the proportion of patients who were less than 
75 years old (38%) was similar over the entire study period. 
Mean age was 72 (SD 11) years overall: 72 (SD 11) years in 
the SHA group and 77 (SD 9.0) years in the RSA group (p 
< 0.001). Females accounted for 80% of the patients in each 
group.
There were 6,112 SHAs (90%) and 565 RSAs (8.4%). 
The most commonly used SHA brands were Bigliani-Flatow 
(Zimmer, Warsaw, IN) (29%), Global Fx (DePuy, Raynham, 
MA) (24%), and Aequalis Fracture (Tornier, Saint-Ismier, 
France) (9%). The most commonly used RSA was Delta 
Xtend (DePuy) (82%).
222 arthroplasties (3.3%) were revised within the period 
(SHA 3.3%, RSA 3.5%). The cumulative survival rates after 
1 year, 5 years, and 10 years were 0.99 (CI: 0.98–0.99), 0.96 
(CI: 0.95–0.96), and 0.95 (CI: 0.94–0.96)  for SHA, and 0.96 
(CI: 0.94–0.98) and 0.96 (CI: 0.94–0.98) for RSA, but data on 
10-year survival rates were not yet available for RSA (Figure 
2). The differences were not statistically signifi cant (p = 0.2). 
The relative risk of revision of RSA compared to SHA was 1.4 
(CI: 0.9–2.2). The most common reason for revision of both 
arthroplasty types was infection (Table 2).
Table 1. Hierarchy of reasons for revision
Hierarchy  Comments
Infection An infection that requires revision of the 
arthroplasty. 
Periprostethic fracture A fracture that requires revision of the 
arthroplasty.
Luxation and instability Instability is only reported as “others” in the 
Danish and the Swedish registries.
Loosening Loosening of any arthroplasty component.
Rotator cuff problem Rotator cuff problem is only reported as 
“others” in the Norwegian registry. 
Others Glenoid wear; biomechanical problems 
including dislocation or overstuffi ng; and 
pain with no other reason reported. 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Year of surgery
1,000
800
600
400
200
0
Stemmed hemiarthroplasty
Reverse shoulder arthroplasty
Count
Figure 1. Distribution of SHA and RSA during the study period.
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Table 2. Reasons for revision after SHA and RSA. 
“Others” include glenoid wear, malpositioning of 
the arthroplasty, and pain with no other reasons 
reported
  SHA RSA
 n % n %
Infection 51 0.8 12 2.1
Periprostethic fracture 8 0.1 1 0.2
Luxation and instability 26 0.4 2 0.4
Loosening 5 0.1 1 0.2
Rotator cuff problem 47 0.8 0 0
Others 50 1.8 3 0.5
Missing 15 0.2 1 0.2
Total 202 3.3 20 3.5
0 2 4 6 8 10
Years from surgery
1.00
0.98
0.96
0.94
0.92
0.90
Stemmed hemiarthroplasty
Reverse shoulder arthroplasty
Cumulative survival
0 2 4 6 8 10
Years from surgery
1.00
0.98
0.96
0.94
0.92
0.90
Stemmed hemiarthroplasty
Reverse shoulder arthroplasty
Cumulative survival, endpoint revision for infection
0 2 4 6 8 10
Years from surgery
1.00
0.98
0.96
0.94
0.92
0.90
age ≥ 75 years
age < 75 years 
Cumulative survival (SHA)
0 2 4 6 8 10
Years from surgery
1.00
0.98
0.96
0.94
0.92
0.90
age ≥ 75 years
age < 75 years 
Cumulative survival (SHA + RSA)
Figure 2. Cumulative survival over the years. Figure 3. Cumulative survival over the 
years, with endpoint revision for infection.
Figure 4. Cumulative survival of both SHA 
and RSA over the years in 2 age groups.
Figure 5. Cumulative survival of SHA 
alone over the years in 2 age groups.
patients (p < 0.001) (Figure 5). The number of RSAs was too 
small for comparison of patients according to age. 
Discussion
We found similar high arthroplasty survival rates for both 
SHA and RSA. The factors that lead to the decision to revise 
are not fully understood, and reported survival rates do not 
necessarily refl ect the functional outcome of the patients. 
Some failures are never revised, and some revisions lead to 
good functional outcome and cannot be considered to be fail-
ures. Acute fracture patients more often have comorbidities 
than elective patients, and are less amenable to revision sur-
gery. Inclusion of a patient-reported outcome in the dataset 
would have added important information to our study. This 
was not possible, however. The Danish and the Swedish regis-
tries use the same patient-reported outcome criteria, but with 
different follow-up times, and the Norwegian registry does not 
systematically register patient-reported outcome (Rasmussen 
et al. 2016).
A low revision rate after fracture hemiarthroplasty, com-
pared to other indications, has been reported. Fevang et al. 
(2009) reported revision rates of 1% and 3% after 5 and 10 
years for SHA for acute fractures. The National Joint Replace-
ment Registry in Australia (Australian Orthopaedic Associa-
tion 2015) reported revision rates of 2.6% for SHA and 2.9% 
for RSA after 1 year, and 7.5% and 4.6% after 5 years. The 
total proportion of revisions covering the period from 2008 to 
2013 was 5.6% for SHA and 3.3% for RSA.
Several systematic reviews have reported postoperative 
complications and revision rates after SHA for acute fractures. 
Kontakis et al. (2008) systematically reviewed 16 studies 
including 810 SHAs for acute fractures. Complication rates 
51 SHAs (0.8%) and 12 RSAs (2.1%) 
were revised because of infection. All revi-
sions of RSA were performed within the fi rst 
postoperative year, while revision of SHAs 
due to infection was done within a period of 
more than 5 years (Figure 3). The relative 
risk of revision due to infection was 3.1 (CI: 
1.6–5.9) for RSA with SHA as reference.
There were 3,758 patients (56%) who 
were less than 75 years old at the time of 
surgery. The relative risk of revision was 2.8 
(CI: 2.0–3.8) compared to older patients. 
The 10-year survival rate was 0.93, which 
was statistically signifi cantly different from 
that in older patients (p < 0.001) (Figure 4). 
In the sub-population of younger patients, 
there were 3,489 SHAs (93%) and 215 RSAs 
(5.7%), of which 159 (4.6%) and 13 (6.0%), 
respectively, were revised. The survival rates 
of patients with SHA who were less than 75 
years old were worse than those for older 
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were provided in 15 studies. They reported complication rates 
of 11% related to tuberosity fi xation, 9% related to hetero-
topic ossifi cation, and 7% related to proximal migration of the 
humeral head. Superfi cial infection was reported in 1.6% and 
deep infection in 0.6%. Revision rate was not clearly reported. 
In a systematic review, Mata-Fink et al. (2013) reported func-
tional outcome in 377 RSAs for acute fractures. They did not 
fi nd more complications than after SHA. Anakwenze et al. 
(2014) systematically reviewed 9 studies covering 247 frac-
tures treated with RSA. Complication data were available for 
172 patients. Scapular notching was reported in 32%, ectopic 
ossifi cation in 9%, dislocations in 4%, and infection in 3%. 
Only 1.2% of the arthroplasties were reoperated. Brorson et 
al. (2013) included 18 studies covering 430 RSAs for acute 
fractures. They reported 1.6% dislocations, 2.1% neurological 
complications, and 1.2% infections. Scapular notching was 
reported in 11 studies (0–94%, median 25%). Reoperation 
rates were not reported. Namdari et al. (2013) systematically 
reviewed 14 studies with 495 patients treated with SHA or 
RSA for acute fractures. They found that RSA was associated 
with a 4.0 times greater risk of a postoperative complication 
compared to SHA. The overall reoperation rate was 6% after 
RSA and 9% after SHA.
Discrepancies in revision rates between systematic reviews 
and data from national registries may be related to inclusion 
criteria. The systematic reviews are based on clinical stud-
ies that often use inclusion and exclusion criteria in order to 
make the population as homogenous as possible, whereas the 
national registries often include all patients irrespective of age 
and comorbidity. Data from clinical studies may be less useful 
for generalization of revision rates and reasons for revision, as 
the number of patients may be low. On the other hand, without 
100% completeness, registry data may hide some systematic 
differences between the reported arthroplasties and those that 
are missing. We do not know the consequences of the lower 
completeness in the Swedish registry, but if relatively higher 
numbers of revision arthroplasties than of primary arthroplas-
ties are missing, the survival rates will be overestimated.
Any comparison of SHA and RSA should be interpreted 
with caution. The RSA is a new design, and it can be hypothe-
sized that it may have been introduced fi rst in the most experi-
enced centers and used in selected patients only. The revision 
procedure for an RSA may be more challenging than revision 
of an SHA, and some surgeons may hesitate to revise an RSA, 
thus leading to an underestimation of the real number of fail-
ures. The patients treated with an RSA were generally older 
than patients treated with SHA, and they may have been in 
a worse medical condition. Moreover, fracture arthroplasties 
are inserted in most centers whereas revision is done only in 
large centers. Surgeons who have performed a primary opera-
tion may hesitate to refer their patients for revision. RSA was 
more often used at the end of the study period, suggesting 
that the indication for RSA in the treatment of acute fractures 
has changed during the study period. The reason for this is 
unclear, but is worth considering. Thus, learning curves  may 
have infl uenced the revision rate for RSA, and as there is no 
control over the indication for the type of arthroplasty, selec-
tion bias may have infl uenced the comparison.
The risk of infection was higher after RSA than after SHA. 
All revisions of RSA due to infection were performed within 
the fi rst postoperative year, while revision of SHA was found 
throughout the study period. The reason for this is not clear, 
but a likely reason is a greater dead space after RSA—which 
could lead to hematoma and infection. Other reasons for a 
higher infection rate after RSA might be the possibly longer 
operation time and an older group in worse medical condition. 
The inclusion of bilateral procedures in the survival analy-
ses violates the assumption of independence. However, previ-
ous studies of hip and knee arthroplasties have reported that 
this has few practical consequences. Furthermore, the Kaplan-
Meier method and the Cox regression model are based on 
the underlying assumption that there is no competing risk 
which is, of course, violated in arthroplasty survival analy-
sis. Patients are censored when they die and will therefore no 
longer be at risk of revision. Thus, the arthroplasty survival 
will be underestimated. Finally, in the Cox regression model 
the assumption of proportional hazards was violated, and the 
hazard ratios may have been overestimated (Ranstam et al. 
2011). The statistical limitations are worth considering when 
our results are being interpreted.  
The present study had some limitations. It had the inher-
ent limitation of observational studies in general and registry 
studies in particular. This includes selection bias, especially in 
terms of choice of arthroplasty type. Furthermore, there is a 
relatively low degree of completeness in the Swedish registry. 
Without 100% completeness, the survival rates are overesti-
mated if the proportion of missing revisions is higher than the 
proportion of missing primary arthroplasties. There were also 
limitations related to the minimal dataset, which only included 
basic variables. Thus, there was no information about comor-
bidity and no patient-reported outcome. 
 In summary, revisions after shoulder arthroplasty in acute 
fractures were rare. Arthroplasty survival was similar between 
SHA and RSA, but RSA had a statistically signifi cant and 
clinically relevant higher risk of revision due to infection than 
SHA. Independently of arthroplasty type, young patients had 
a statistically signifi cant and clinically relevant higher risk of 
revision than older patients.
This paper is the result of collaboration between representatives of the Nordic 
national registries. All authors participated in the conception and design of 
the study, and in interpretation of the results. AMF, BS, and JVR prepared 
data from the national registries. JVR performed the statistical analysis. SB, 
YD, AMF, and BS participated in preparation of the manuscript. JVR incor-
porated input from all the other authors and was responsible for writing the 
manuscript.   
We thank the orthopedic surgeons in Denmark, Norway, and Sweden for data 
reporting.
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